Putting Georgia's Patients First Act; enact
HB 227, titled the "Putting Georgia's Patients First Act," makes broad revisions to Georgia’s medical cannabis laws by renaming “low THC oil” as “medical cannabis” throughout the Code and updating related definitions, registries, licensing provisions, and criminal statutes. The bill keeps the existing framework for lawful possession and use by registered patients, but it modernizes terminology, expands public education duties for the Georgia Access to Medical Cannabis Commission, and revises rules for licensees, including location restrictions, advertising limits, and information-sharing standards.
The bill also revises the list of qualifying conditions for a medical cannabis registration card. In addition to existing conditions, it expressly includes lupus and makes several clarifications to conditions such as cancer, ALS, multiple sclerosis, Parkinson’s disease, sickle cell disease, autism spectrum disorder, PTSD, peripheral neuropathy, and others. It further updates the statutory treatment of medical cannabis under Georgia’s controlled substances laws so that lawful possession and control by authorized persons is excluded from marijuana and Schedule I definitions, while preserving criminal penalties for unauthorized possession, manufacture, distribution, and trafficking.
HB 227 would amend multiple titles of the Official Code of Georgia Annotated, including agriculture, criminal law, public health, tort liability, and controlled substances. Its main legal effect is to replace the term "low THC oil" with "medical cannabis" across Georgia law, while preserving and refining the state’s medical cannabis program, patient registry, licensing system, and enforcement provisions. It also expands the list of qualifying medical conditions and clarifies that authorized medical cannabis is not treated as marijuana or a Schedule I controlled substance for lawful users and licensees.
The available voting history shows strong support for the bill in the House, where it passed 164-1 on February 27, 2025. The caption and structure of the bill suggest a patient-focused measure intended to improve clarity and access within Georgia’s medical cannabis program. No committee transcript is available, but the overwhelming vote indicates broad bipartisan or near-unanimous agreement on the need for the revisions.
The bill’s likely points of contention are the scope of the medical cannabis program and the balance between patient access and regulatory control. Potential issues include the addition of new qualifying conditions, the redefinition of cannabis-related terms in criminal law, and the limits placed on advertising, licensing, and proximity to schools, child care programs, and houses of worship. Another area of sensitivity is the bill’s careful preservation of criminal penalties for unauthorized possession and trafficking, which reflects an effort to expand lawful access without loosening enforcement against noncompliant activity.